Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Biomolecules & Therapeutics ; : 406-413, 2014.
Artículo en Inglés | WPRIM | ID: wpr-145966

RESUMEN

A substantial proportion of patients with autism spectrum disorder (ASD) display hyperactivity as a comorbid symptom. Exposure to valproic acid (VPA) during pregnancy produces ASD-like core behavioral phenotypes as well as hyperactivity in offspring both in human and experimental animals, which makes it a plausible model to study ASD-related neurobiological processes. In this study, we examined the effects of two of currently available attention defecit hyperactivity disorder (ADHD) medications, methylphenidate (MPH) and atomoxetine (ATX) targeting dopamine and norepinephrine transporters (DAT and NET), respectively, on hyperactive behavior of prenatally VPA-exposed rat offspring. In the prefrontal cortex of VPA exposed rat offspring, both mRNA and protein expression of DAT was increased as compared with control. VPA function as a histone deacetylase inhibitor (HDACi) and chromatin immunoprecipitation experiments demonstrated that the acetylation of histone bound to DAT gene promoter was increased in VPA-exposed rat offspring suggesting epigenetic mechanism of DAT regulation. Similarly, the expression of NET was increased, possibly via increased histone acetylation in prefrontal cortex of VPA-exposed rat offspring. When we treated the VPA-exposed rat offspring with ATX, a NET selective inhibitor, hyperactivity was reversed to control level. In contrast, MPH that inhibits both DAT and NET, did not produce inhibitory effects against hyperactivity. The results suggest that NET abnormalities may underlie the hyperactive phenotype in VPA animal model of ASD. Profiling the pharmacological responsiveness as well as investigating underlying mechanism in multiple models of ASD and ADHD may provide more insights into the neurobiological correlates regulating the behavioral abnormalities.


Asunto(s)
Animales , Niño , Humanos , Embarazo , Ratas , Acetilación , Trastorno Autístico , Trastorno del Espectro Autista , Inmunoprecipitación de Cromatina , Dopamina , Epigenómica , Inhibidores de Histona Desacetilasas , Histonas , Metilfenidato , Modelos Animales , Norepinefrina , Proteínas de Transporte de Noradrenalina a través de la Membrana Plasmática , Fenotipo , Corteza Prefrontal , ARN Mensajero , Ácido Valproico , Clorhidrato de Atomoxetina
2.
Experimental & Molecular Medicine ; : 84-96, 2007.
Artículo en Inglés | WPRIM | ID: wpr-37552

RESUMEN

Various cell types in higher multicellular organisms are genetically homogenous, but are functionally and morphologically heterogeneous due to the differential expression of genes during development, which appears to be controlled by epigenetic mechanisms. However, the exact molecular mechanisms that govern the tissue-specific gene expression are poorly understood. Here, we show that dynamic changes in histone modifications and DNA methylation in the upstream coding region of a gene containing the transcription initiation site determine the tissue-specific gene expression pattern. The tissue-specific expression of the transgene correlated with DNA demethylation at specific CpG sites as well as significant changes in histone modifications from a low ratio of methylated H3- lysine 4 or acetylated H3-lysine 9, 14 to acetylated H4 to higher ratios. Based on the programmed status of transgene silenced in cloned mammalian ear-derived fibroblasts, the transgene could be reprogrammed by change of histone modification and DNA methylation by inhibiting both histone deacetylase and DNA methylation, resulting in high expression of the transgene. These findings indicate that dynamic change of histone modification and DNA methylation is potentially important in the establishment and maintenance of tissue-specific gene expression.


Asunto(s)
Animales , Transgenes/genética , Porcinos , Especificidad de Órganos/genética , Metilación , Lisina/metabolismo , Histonas/metabolismo , Histona Desacetilasas/metabolismo , Silenciador del Gen , Expresión Génica , Fibroblastos , Oído , Metilación de ADN , Células Cultivadas , Animales Modificados Genéticamente , Acetilación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA